STOCK TITAN

Clover Health (CLOV) insider files to sell 51,700 shares of common stock

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Clover Health Investments (CLOV) insider Karen Soares filed to sell up to 51,700 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of $238,854.00. The securities relate to Restricted Stock Units granted on 03/15/2026, with additional sales already made in the past three months.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 51,700 shares Common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services
Aggregate market value of planned sale $238,854.00 Aggregate market value for the 51,700 shares covered by the Form 144
Shares outstanding 430,969,398 shares Common shares outstanding for context to the planned sale
Sale date referenced 07/20/2026 Date associated with the proposed sale of 51,700 shares
Prior sale on 07/15/2026 10,519 shares for $49,123.73 Common shares sold in the three months preceding the notice
Prior sale on 06/15/2026 4,681 shares for $21,579.41 Common shares sold in the three months preceding the notice
RSU grant date 03/15/2026 Date of Restricted Stock Units from which the common shares derive
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Units financial
"Restricted Stock Units | Issuer | | | 51700 | 03/15/2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
aggregate market value financial
"51700 | 238854.00 | 430969398 | 07/20/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
common stock financial
"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the Form 144 filing for CLOV by Karen Soares disclose?

The filing shows Karen Soares plans to sell up to 51,700 shares of Clover Health common stock, valued at $238,854.00, through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

How many CLOV shares has Karen Soares sold in the last three months?

The filing lists prior sales of 10,519 shares for $49,123.73 on 07/15/2026 and 4,681 shares for $21,579.41 on 06/15/2026, totaling 15,200 shares during the past three months.

What type of CLOV securities are covered by Karen Soares’ Form 144?

The Form 144 covers common stock related to Restricted Stock Units that were issued by the company on 03/15/2026, which are now eligible for potential resale under Rule 144.

What is the aggregate market value of CLOV shares Karen Soares may sell?

The potential sale of up to 51,700 shares of Clover Health common stock is reported with an aggregate market value of $238,854.00, based on the pricing used in the Form 144.

How many CLOV shares are reported as outstanding in this Form 144?

The filing lists 430,969,398 Clover Health common shares as outstanding, providing context for the potential sale of 51,700 shares under this Form 144 notice.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature